Dr. Anna Kirsch
Person

Affiliations

Department of Anesthesiology and Intensive Care Medicine
- Academic Staff
- anna.kirsch@ukdd.de
- anna.kirsch@tu-dresden.de

Identification Numbers

ORCID	0009-0007-3869-8765
Scopus author ID	57193845406

Nucleated red blood cells as a prognostic marker for mortality in septic critically ill patients: An observational study

Niebhagen, F. (First author), Kirsch, A., Schau, R., Waske, S., Heubner, L., Mirus, M. & Rand, A. & 8 others, Güldner, A., Held, H.-C., Schneider, R., Bodechtel, U., Mehrholz, J., Koch, T., Spieth, P. M. & Menk, M. (Last author), Nov 2025, In: Anaesthesia, critical care & pain medicine. 44, 6, 1 p., 101605.

Research output: Contribution to journal › Research article › Contributed › peer-review

Long-term characteristics and outcomes of septic critically ill patients with and without COVID-19

Niebhagen, F. (Joint first author), Heubner, L. (Joint first author), Kirsch, A., Güldner, A., Held, H.-C., Schneider, R. & Bodechtel, U. & 4 others, Mehrholz, J., Koch, T., Menk, M. (Joint last author) & Spieth, P. M. (Joint last author), Feb 2025, In: Journal of Critical Care. 85, 6 p., 154942.

Research output: Contribution to journal › Research article › Contributed › peer-review

Nucleated red blood cells as a prognostic marker for mortality in patients with SARS-CoV-2-induced ARDS: an observational study

Kirsch, A., Niebhagen, F., Goldammer, M., Waske, S., Heubner, L., Petrick, P. & Güldner, A. & 3 others, Koch, T., Spieth, P. & Menk, M., 28 Jun 2024, In: Journal of Anesthesia, Analgesia and Critical Care. 4 (2024), 1, 14 p., 38.

Research output: Contribution to journal › Research article › Contributed › peer-review

Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)

Kessler, T., Koschmieder, S., Schliemann, C., Crysandt, M., Mikesch, J.-H., von Stillfried, S. & Stelljes, M. & 11 others, Pohlen, M., Lenz, G., Kirsch, A., Vehring, K., Wardelmann, E., Hartmann, W., Bormann, E., Gerss, J., Brümmendorf, T. H., Müller-Tidow, C. & Berdel, W. E., Jun 2019, In: Annals of hematology. 98, 6, p. 1393-1401 9 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (4)

Research Portal of the TU Dresden

Dr. Anna Kirsch
Person

Affiliations

Identification Numbers

Related content

Nucleated red blood cells as a prognostic marker for mortality in septic critically ill patients: An observational study

Long-term characteristics and outcomes of septic critically ill patients with and without COVID-19

Nucleated red blood cells as a prognostic marker for mortality in patients with SARS-CoV-2-induced ARDS: an observational study

Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)